EPIRIUM

Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules that constitute a new class of therapeutics with the potential to improve function in neuromuscular diseases, including sarcopenia and spinal muscular atrophy. We have generated preclinical data in a broader scope of indications with significant unmet medical need, including fibrosis, which our development pipeline has the potential to address... Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company... Epirium Bio, a biopharmaceutical company based in San Diego, is developing a small molecule platform targeting improvements in muscle strength, tissue regeneration and mitochondrial function. Our focus is on muscle and neuromuscular diseases. We have encouraging data in non-muscle indications, highlighting..

Also known as: Epirium Bio